Matches in SemOpenAlex for { <https://semopenalex.org/work/W3122414313> ?p ?o ?g. }
- W3122414313 abstract "Chronic lymphocytic leukemia (CLL) is a malignancy of mature, antigen-experienced B lymphocytes. Despite great progress recently achieved in the management of CLL, the disease remains incurable, underscoring the need for further investigation into the underlying pathophysiology. Microenvironmental crosstalk has an established role in CLL pathogenesis and progression. Indeed, the malignant CLL cells are strongly dependent on interactions with other immune and non-immune cell populations that shape a highly orchestrated network, the tumor microenvironment (TME). The composition of the TME, as well as the bidirectional interactions between the malignant clone and the microenvironmental elements have been linked to disease heterogeneity. Mounting evidence implicates T cells present in the TME in the natural history of the CLL as well as in the establishment of certain CLL hallmarks e.g. tumor evasion and immune suppression. CLL is characterized by restrictions in the T cell receptor gene repertoire, T cell oligoclonal expansions, as well as shared T cell receptor clonotypes amongst patients, strongly alluding to selection by restricted antigenic elements of as yet undisclosed identity. Further, the T cells in CLL exhibit a distinctive phenotype with features of “exhaustion” likely as a result of chronic antigenic stimulation. This might be relevant to the fact that, despite increased numbers of oligoclonal T cells in the periphery, these cells are incapable of mounting effective anti-tumor immune responses, a feature perhaps also linked with the elevated numbers of T regulatory subpopulations. Alterations of T cell gene expression profile are associated with defects in both the cytoskeleton and immune synapse formation, and are generally induced by direct contact with the malignant clone. That said, these abnormalities appear to be reversible, which is why therapies targeting the T cell compartment represent a reasonable therapeutic option in CLL. Indeed, novel strategies, including CAR T cell immunotherapy, immune checkpoint blockade and immunomodulation, have come to the spotlight in an attempt to restore the functionality of T cells and enhance targeted cytotoxic activity against the malignant clone." @default.
- W3122414313 created "2021-02-01" @default.
- W3122414313 creator A5018681513 @default.
- W3122414313 creator A5034892288 @default.
- W3122414313 creator A5044130307 @default.
- W3122414313 date "2021-01-20" @default.
- W3122414313 modified "2023-10-17" @default.
- W3122414313 title "T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword" @default.
- W3122414313 cites W101553012 @default.
- W3122414313 cites W1243376384 @default.
- W3122414313 cites W1429374962 @default.
- W3122414313 cites W1507800008 @default.
- W3122414313 cites W1602091308 @default.
- W3122414313 cites W1690008797 @default.
- W3122414313 cites W1769604497 @default.
- W3122414313 cites W1809040828 @default.
- W3122414313 cites W1973249762 @default.
- W3122414313 cites W1976400767 @default.
- W3122414313 cites W1981784297 @default.
- W3122414313 cites W1984999956 @default.
- W3122414313 cites W1989773575 @default.
- W3122414313 cites W1993598575 @default.
- W3122414313 cites W1998161202 @default.
- W3122414313 cites W2001710477 @default.
- W3122414313 cites W2005484484 @default.
- W3122414313 cites W2007592680 @default.
- W3122414313 cites W2011458181 @default.
- W3122414313 cites W2020029911 @default.
- W3122414313 cites W2025948154 @default.
- W3122414313 cites W2027915986 @default.
- W3122414313 cites W2030086461 @default.
- W3122414313 cites W2032553162 @default.
- W3122414313 cites W2036384264 @default.
- W3122414313 cites W2037198742 @default.
- W3122414313 cites W2038421089 @default.
- W3122414313 cites W2038592860 @default.
- W3122414313 cites W2039427849 @default.
- W3122414313 cites W2042765435 @default.
- W3122414313 cites W2046972425 @default.
- W3122414313 cites W2049590903 @default.
- W3122414313 cites W2063472958 @default.
- W3122414313 cites W2066373927 @default.
- W3122414313 cites W2075736621 @default.
- W3122414313 cites W2084870802 @default.
- W3122414313 cites W2085653402 @default.
- W3122414313 cites W2088619423 @default.
- W3122414313 cites W2089103836 @default.
- W3122414313 cites W2090851216 @default.
- W3122414313 cites W2093538016 @default.
- W3122414313 cites W2095447519 @default.
- W3122414313 cites W2095491662 @default.
- W3122414313 cites W2098166849 @default.
- W3122414313 cites W2099023072 @default.
- W3122414313 cites W2099468505 @default.
- W3122414313 cites W2101853479 @default.
- W3122414313 cites W2103876938 @default.
- W3122414313 cites W2104168678 @default.
- W3122414313 cites W2107598346 @default.
- W3122414313 cites W2108367695 @default.
- W3122414313 cites W2111609050 @default.
- W3122414313 cites W2113127251 @default.
- W3122414313 cites W2116324811 @default.
- W3122414313 cites W2117775564 @default.
- W3122414313 cites W2119896120 @default.
- W3122414313 cites W2121827939 @default.
- W3122414313 cites W2122792339 @default.
- W3122414313 cites W2125258954 @default.
- W3122414313 cites W2125647853 @default.
- W3122414313 cites W2133449188 @default.
- W3122414313 cites W2135215267 @default.
- W3122414313 cites W2138145008 @default.
- W3122414313 cites W2142604595 @default.
- W3122414313 cites W2154707187 @default.
- W3122414313 cites W2155499644 @default.
- W3122414313 cites W2158148898 @default.
- W3122414313 cites W2158313081 @default.
- W3122414313 cites W2161134240 @default.
- W3122414313 cites W2165814241 @default.
- W3122414313 cites W2192121806 @default.
- W3122414313 cites W2204986825 @default.
- W3122414313 cites W2232549736 @default.
- W3122414313 cites W2233614027 @default.
- W3122414313 cites W2241302377 @default.
- W3122414313 cites W2254907138 @default.
- W3122414313 cites W2291618069 @default.
- W3122414313 cites W2324641152 @default.
- W3122414313 cites W2330978427 @default.
- W3122414313 cites W2347101381 @default.
- W3122414313 cites W2546622097 @default.
- W3122414313 cites W2559115935 @default.
- W3122414313 cites W2560661681 @default.
- W3122414313 cites W2564152524 @default.
- W3122414313 cites W2580312756 @default.
- W3122414313 cites W2585539786 @default.
- W3122414313 cites W2599601523 @default.
- W3122414313 cites W2605683323 @default.
- W3122414313 cites W2613683808 @default.
- W3122414313 cites W2620623199 @default.
- W3122414313 cites W2623503441 @default.
- W3122414313 cites W2679405192 @default.